Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
British Journal of Haematology|October 28, 2008
Remission induction therapy containing rituximab markedly improved the outcome of untreated mature B cell lymphomaHirokazu Nagai, Takahiro Yano, Tomoyuki Watanabe, et al.
International Journal of Hematology|March 12, 2003
Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study (JCOG9109)Kunihiro Tsukasaki, Kensei Tobinai, Masanori Shimoyama, et al.
International Journal of Hematology|December 2, 2015
A phase I study of vorinostat combined with bortezomib in Japanese patients with relapsed or refractory multiple myelomaYoshiaki Ogawa, Michinori Ogura, Kensei Tobinai, et al.
Human Immunology|March 2, 2002
Human umbilical cord blood NK T cells kill tumors by multiple cytotoxic mechanismsBalgansuren Gansuvd, Masao Hagihara, Ying Yu, et al.
European Journal of Haematology|November 13, 2010
Cladribine combined with rituximab (R-2-CdA) therapy is an effective salvage therapy in relapsed or refractory indolent B-cell non-Hodgkin lymphomaHirokazu Nagai, Michinori Ogura, Shigeru Kusumoto, et al.
International Journal of Hematology|January 15, 2008
Prognostic significance of FLT3 internal tandem duplication and NPM1 mutations in acute myeloid leukemia in an unselected patient populationRikio Suzuki, Makoto Onizuka, Minoru Kojima, et al.
American Journal of Hematology|July 27, 2007
Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein-Barr virus infectionTakuya Miyazaki, Katsumichi Fujimaki, Yukari Shirasugi, et al.
Pageof 12